July/August 2015

Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus

September 24, 2015

The American Journal of Pharmacy Benefits

In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.

Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic Therapy

September 23, 2015

The American Journal of Pharmacy Benefits

Adherence classes were determined for patients taking multiple medications (ie, lipid-lowering, antihypertensive, antidiabetic) and were found to be related to serum profiles and risk of adverse events.

What Roles Do Patient Characteristics Play in Value-Based Performance?

August 21, 2015

The American Journal of Pharmacy Benefits

Incorporating patient-related sociodemographic factors into performance measurement systems is essential for providing an accurate assessment of the quality of care delivered.

E-Prescribing Is Becoming a Standard of Care

August 21, 2015

The American Journal of Pharmacy Benefits

E-prescribing adoption has increased dramatically over the past decade. This study provides empirical evidence that utilization among adopters continues to increase, suggesting application “stickiness.”

Is PBM Transparency an Answer to Controlling Rising Drug Costs?

August 21, 2015

The American Journal of Pharmacy Benefits

With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.

Going the Extra Step to Enhance the Exchanges

August 20, 2015

The American Journal of Pharmacy Benefits

Which states can policy makers look to as leaders in creating patient-focused health insurance markets? A series of state-by-state progress reports holds the answer.